UPC2 Is Universally Essential for Azole Antifungal Resistance in Candida albicans
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
In Candida albicans , the transcription factor Upc2 is central to the regulation of ergosterol biosynthesis. UPC2 -activating mutations contribute to azole resistance, whereas disruption increases azole susceptibility. In the present study, we investigated the relationship of UPC2 to fluconazole susceptibility, particularly in azole-resistant strains. In addition to the reduced fluconazole MIC previously observed with UPC2 disruption, we observed a lower minimum fungicidal concentration (MFC) for a upc2 Δ/Δ mutant than for its azole-susceptible parent, SC5314. Moreover, the upc2 Δ/Δ mutant was unable to grow on a solid medium containing 10 μg/ml fluconazole and exhibited increased susceptibility and a clear zone of inhibition by Etest. Time-kill analysis showed higher fungistatic activity against the upc2 Δ/Δ mutant than against SC5314. UPC2 disruption in strains carrying specific resistance mutations also resulted in reduced MICs and MFCs. UPC2 disruption in a highly azole resistant clinical isolate containing multiple resistance mechanisms likewise resulted in a reduced MIC and MFC. This mutant was unable to grow on a solid medium containing 10 μg/ml fluconazole and exhibited increased susceptibility and a clear zone of inhibition by Etest. Time-kill analysis showed increased fungistatic activity against the upc2 Δ/Δ mutant in the resistant background. Microarray analysis showed attenuated induction by fluconazole of genes involved in sterol biosynthesis, iron transport, or iron homeostasis in the absence of UPC2 . Taken together, these data demonstrate that the UPC2 transcriptional network is universally essential for azole resistance in C. albicans and represents an attractive target for enhancing azole antifungal activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“UPC2, which encodes a major transcriptional regulator of ergosterol biosynthesis 54 , affected both RAD and FoG levels significantly, while two regulators of efflux pump transcription had no significant effect, consistent with the redundancy of efflux mechanisms 55 (Fig. 4e).”
From Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia (2018) · cites this paper as [54]
In the citing paper
“Upc2 is a global ergosterol-synthesis-related gene regulator contributing to FLC tolerance [40,41].”
From Pitavastatin Calcium Confers Fungicidal Properties to Fluconazole by Inhibiting Ubiquinone Biosynthesis and Generating Reactive Oxygen Species (2024) · cites this paper as [40]
In the citing paper
“Vasicek et al. reported that activation of Upc2 induces azole resistance in C. albicans, whereas dysfunction of Upc2 enhances the sensitivity of C. albicans to azoles [15].”
From Disruption of the UPC2 Gene Enhances Fluconazole Antifungal Activity by Inhibiting HAC1 mRNA Splicing in Candida albicans (2026) · cites this paper as [15]
In the citing paper
“Similarly, pitavastatin interacted synergistically with fluconazole against C. albicans SC-TAC1G980E strain, which has a gain of function mutation in TAC1, a positive transcription regulator for the ABC (ATP Binding Cassette) membrane transporters29–31.”
From Repurposing approach identifies pitavastatin as a potent azole chemosensitizing agent effective against azole-resistant Candida species (2020) · cites this paper as [30]
In the citing paper
“However, the pitavastatin-fluconazole combination failed to display similar interactions against strain TWO7241, which exhibits increased mRNA levels of both ERG11 and MDR1, and strain SC-MRR1P683S which has a gain of function mutation in MRR1, a positive transcription regulator for the MFS (Major Facilitator Superfamily) membrane transporters29–31.”
From Repurposing approach identifies pitavastatin as a potent azole chemosensitizing agent effective against azole-resistant Candida species (2020) · cites this paper as [30]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Ghannoum, M. A., & Rice, L. B. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.4.501 · Cited by 1,785 · cited 1×
“Integration of these sterols into the plasma membrane disrupts its integrity, resulting in its altered structure and function (12, 43, 44).”
BackgroundClinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353 · cited 1×
“Currently known mechanisms of resistance to the azoles include alterations in the expression of drug efflux pump (CDR1, CDR2, and MDR1) and ergosterol biosynthesis (ERG) genes and mutations in ERG11 (18).”
BackgroundA rapid and simple method for preparation of RNA from Saccharomyces cerevisiae
Schmitt, M. E., Brown, T. A., & Trumpower, B. L. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.10.3091 · Cited by 1,338
Attributable Mortality of Nosocomial Candidemia, Revisited
Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140
Cell Wall Integrity Signaling in Saccharomyces cerevisiae
Levin, D. E. (2005) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.69.2.262-291.2005 · Cited by 1,136 · cited 1×
“compromised host, the fungistatic nature of fluconazole limits its efficacy against Candida species (14, 15).”
BackgroundReference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard
Rex, J. H., & Clinical (2008) · Clinical and Laboratory Standards Institute eBooks · Cited by 1,052
Klein, R. S., Harris, C. A., Small, C. B., Moll, B., Lesser, M., & Friedland, G. H. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408093110602 · Cited by 863
The SAT1 flipper, an optimized tool for gene disruption in Candida albicans
Reuß, O., Vik, Å., Kolter, R., & Morschhäuser, J. (2004) · Gene · doi:10.1016/j.gene.2004.06.021 · Cited by 742 · cited 3×
“Plasmid pSFS2 contains the entire SAT1-flipper cassette (24).”
BackgroundMethodInfluentialEpidemiology of Nosocomial Fungal Infections, with Emphasis on Candida Species
Jarvis, W. R. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.6.1526 · Cited by 636
White, T. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1482 · Cited by 612
Cited by
Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00199 · Cited by 801
Regulation of Ergosterol Biosynthesis in Saccharomyces cerevisiae
Jordá, T., & Puig, S. (2020) · Genes · doi:10.3390/genes11070795 · Cited by 489
“albicans sensitivity to azole treatments, even in highly azole resistant clinical isolates containing multiple resistance mechanisms [70,77].”
BackgroundRosenberg, A., Ene, I. V., Bibi, M., Zakin, S., Segal, E. S., Ziv, N., Dahan, A. M., Colombo, A. L., Bennett, R. J., & Berman, J. (2018) · Nature Communications · doi:10.1038/s41467-018-04926-x · Cited by 270
The Fungal CYP51s: Their Functions, Structures, Related Drug Resistance, and Inhibitors
Zhang, J., Li, L., Lv, Q., Yan, L., Wang, Y., & Jiang, Y. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00691 · Cited by 245
“glabrata is deleted, the susceptibility to azoles will be enhanced (Guida et al., 2011; Vasicek et al., 2014; Whaley et al., 2014).”
BackgroundStructural mechanism of ergosterol regulation by fungal sterol transcription factor Upc2
Yang, H., Tong, J., Lee, C. W., Ha, S., Eom, S. H., & Im, Y. J. (2015) · Nature Communications · doi:10.1038/ncomms7129 · Cited by 223
Adapting to survive: How Candida overcomes host-imposed constraints during human colonization
Alves, R., Barata-Antunes, C., Casal, M., Brown, A. J. P., Van Dijck, P., & Paiva, S. (2020) · PLOS Pathogens · doi:10.1371/journal.ppat.1008478 · Cited by 122
Defining the frontiers between antifungal resistance, tolerance and the concept of persistence
Delarze, E., & Sanglard, D. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.10.001 · Cited by 118
“albicans mutant lacking the ranscriptional activator UPC2 was killed by fluconazole as opposed o wild type (Vasicek et al., 2014).”
BackgroundAbnormal Ergosterol Biosynthesis Activates Transcriptional Responses to Antifungal Azoles
Hu, C., Zhou, M., Wang, W., Sun, X., Yarden, O., & Li, S. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00009 · Cited by 114
“…efflux pumps and Upc2p that regulates ergosterol biosynthesis genes in C. albicans, govern the expression of many azole-responsive genes and confer azole resistance (Coste et al., 2004; Coste et al., 2006; Dunkel et al., 2008; Heilmann et al., 2010; Flowers et al., 2012; Vasicek et al., 2014).”
BackgroundNishimoto, A. T., Sharma, C., & Rogers, P. D. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz400 · Cited by 102
Self-citationKoselny, K., Green, J., DiDone, L., Halterman, J. P., Fothergill, A. W., Wiederhold, N. P., Patterson, T. F., Cushion, M. T., Rappelye, C., Wellington, M., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01061-16 · Cited by 83
“Primers for the targets and conditions for RT-PCR were exactly as previously reported (23).”
MethodBurrack, L. S., Todd, R. T., Soisangwan, N., Wiederhold, N. P., & Selmecki, A. (2022) · mBio · doi:10.1128/mbio.00842-22 · Cited by 82
Branco, J., Ola, M., Silva, R. M., Fonseca, E. S. S., Gomes, N. C., Martins-Cruz, C., Silva, A. P., Silva-Dias, A., Pina‐Vaz, C., Erraught, C., et al. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.02.002 · Cited by 75
Ergosterol Biosynthesis and Regulation Impact the Antifungal Resistance and Virulence of Candida spp
Eliaš, D., Tóth Hervay, N., & Gbelská, Y. (2024) · Stresses · doi:10.3390/stresses4040041 · Cited by 63
“Deletion of the UPC2 gene increased susceptibility of yeast cells to azoles and other drugs targeting sterol biosynthesis (terbinafine, fenpropimorph and lovastatin) in various Candida spp. [49,68,69,71,73,74].”
Koselny, K., Green, J., Favazzo, L., Glazier, V. E., DiDone, L., Ransford, S., & Krysan, D. J. (2016) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5b00134 · Cited by 61
Shivarathri, R., Tscherner, M., Zwolanek, F., Singh, N. K., Chauhan, N., & Kuchler, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-45817-5 · Cited by 58
Dong, P., Zong, C., Dagher, Z., Hui, J., Li, J., Zhan, Y., Zhang, M., Mansour, M. K., & Cheng, J. (2021) · Science Advances · doi:10.1126/sciadv.abd5230 · Cited by 60
“Azoles, another major class of antifungals, are used to target ERG11 to inhibit the biosynthesis of ergosterol.”
BackgroundInfluentialEldesouky, H. E., Salama, E. A., Li, X., Hazbun, T. R., Mayhoub, A. S., & Seleem, M. N. (2020) · Scientific Reports · doi:10.1038/s41598-020-64571-7 · Cited by 55
Dannaoui, É., & Espinel‐Ingroff, A. (2019) · Journal of Fungi · doi:10.3390/jof5040108 · Cited by 64
Candida tropicalis distribution and drug resistance is correlated with ERG11 and UPC2 expression
Wang, D., An, N., Yang, Y., Yang, X., Fan, Y., & Feng, J. (2021) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-021-00890-2 · Cited by 52
Regulation of Ergosterol Biosynthesis in Pathogenic Fungi: Opportunities for Therapeutic Development
Song, L., Wang, S., Zou, H., Yi, X., Jia, S., Li, R., & Song, J. (2025) · Microorganisms · doi:10.3390/microorganisms13040862 · Cited by 64
“Upc2 directly binds to sterol regulatory elements (SREs) in the promoters of key ergosterol biosynthesis genes, including erg2p , erg7p , erg11p , and erg25p , thus controlling their expression [53].”
Emerging Mechanisms of Drug Resistance in Candida albicans
Prasad, R., Nair, R., & Banerjee, A. (2019) · Progress in molecular and subcellular biology · doi:10.1007/978-3-030-13035-0_6 · Cited by 45
Liu, J., Yuan, Y., Wu, Z. Q., Li, N., Chen, Y., Qin, T., Geng, H., Li, X., & Liu, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117115 · Cited by 42
Feng, Y., Lu, H., Whiteway, M., & Jiang, Y. (2023) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2023.10.019 · Cited by 40
Structural basis for activation of fungal sterol receptor Upc2 and azole resistance
Tan, L., Chen, L., Yang, H., Jin, B., Kim, G., & Im, Y. J. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01117-0 · Cited by 38
Vasicek, E. M., Berkow, E. L., Bruno, V. M., Mitchell, A. P., Wiederhold, N. P., Barker, K. S., & Rogers, P. D. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00064-14 · Cited by 36
“When UPC2 is constitutively active, ergosterol biosynthesis genes are upregulated, and cellular ergosterol content increases (29), consequently impacting membrane fluidity, which affects cell wall composition (47).”
BackgroundResultSelf-citationManzano, D., Andrade, P., Caudepón, D., Altabella, T., Arró, M., & Ferrer, A. (2016) · PLANT PHYSIOLOGY · doi:10.1104/pp.16.00431 · Cited by 40
Mount, H. O., Revie, N. M., Todd, R. T., Anstett, K., Collins, C., Costanzo, M., Boone, C., Robbins, N., Selmecki, A., & Cowen, L. E. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007319 · Cited by 34
Upc2-mediated mechanisms of azole resistance in Candida auris
Li, J., Aubry, L., Brandalise, D., Coste, A. T., Sanglard, D., & Lamoth, F. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.03526-23 · Cited by 33
“The transcription factor Upc2 was shown to be a key regulator of azole resistance in Candida spp. (12, 20).”
BackgroundResultInfluentialEldesouky, H. E., Salama, E. A., Hazbun, T. R., Mayhoub, A. S., & Seleem, M. N. (2020) · Scientific Reports · doi:10.1038/s41598-020-62976-y · Cited by 33
Cruz, M. R., Cristy, S., Guha, S., De Cesare, G. B., Evdokimova, E., Sanchez, H., Borek, D., Miramón, P., Yano, J., Fidel, P. L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33613-1 · Cited by 30
Lu, H., Li, W., Whiteway, M., Wang, H., Zhu, S., Ji, Z., Feng, Y., Yan, L., Fang, T., Li, L., et al. (2023) · mBio · doi:10.1128/mbio.02639-22 · Cited by 30
“albicans, Upc2 not only contributes to FLC tolerance but also contributes to FLC resistance (45).”
BackgroundJia, C., Zhang, K., Yu, Q., Zhang, B., Xiao, C., Dong, Y., Chen, Y., Zhang, B., Xing, L., & Li, M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.08.005 · Cited by 26
Glazier, V. E., Murante, T., Koselny, K., Murante, D., Esqueda, M., Wall, G., Wellington, M. A., Hung, C.-Y., Kumar, A., & Krysan, D. J. (2018) · G3 Genes Genomes Genetics · doi:10.1534/g3.117.300515 · Cited by 25
“Two heterozygotes, upc2D and crz1D, were hypersensitive to fluconazole, which is consistent with their well-characterized roles in the cellular response to this drug (Vasicek et al. 2014; Onyewu et al. 2004).”
BackgroundThe Microevolution of Antifungal Drug Resistance in Pathogenic Fungi
Boyce, K. J. (2023) · Microorganisms · doi:10.3390/microorganisms11112757 · Cited by 29
“The disruption of UPC2 in C. albicans increases azole susceptibility and over-expression or activating mutations cause azole resistance in vitro [51,52].”
Nishimoto, A. T., Zhang, Q., Hazlett, B., Morschhäuser, J., & Rogers, P. D. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00078-19 · Cited by 24
Self-citationCandida albicans reprioritizes metal handling during fluconazole stress
Hunsaker, E. W., & Franz, K. J. (2019) · Metallomics · doi:10.1039/c9mt00228f · Cited by 22
Small molecules restore azole activity against drug-tolerant and drug-resistant Candida isolates
Alabi, P., Gautier, C., Murphy, T. P., Gu, X., Lepas, M., Aimanianda, V., Sello, J. K., & Ene, I. V. (2023) · mBio · doi:10.1128/mbio.00479-23 · Cited by 30
Shrivastava, M., Kouyoumdjian, G. S., Kirbizakis, E., Ruiz, D., Henry, M., Vincent, A. T., Sellam, A., & Whiteway, M. S. (2023) · mBio · doi:10.1128/mbio.01807-23 · Cited by 24
“This increase in ergosterol pathway gene expression was, however, not associated with upregulation of the classic ergosterol biosynthesis pathway transcription factor Upc2, which functions as a key regulator of the pathway in both S. cerevisiae and C. albicans (34–36).”
BackgroundPasquali, M., Pallez-Barthel, M., & Beyer, M. (2020) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2020.02.006 · Cited by 22
Rashid, S., Correia-Mesquita, T. O., Godoy, P., Omran, R. P., & Whiteway, M. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.764711 · Cited by 15
“9-fold down in the spt7 mutant; Upc2 is a transcription factor that is central to the regulation of ergosterol biosynthesis (Vasicek et al., 2014) and is 2.”
BackgroundLi, W., Feng, Y., Feng, Z., Wang, L., Whiteway, M., Lu, H., & Jiang, Y. (2024) · Antioxidants · doi:10.3390/antiox13060667 · Cited by 14
“Upc2 is a global ergosterol-synthesis-related gene regulator contributing to FLC tolerance [40,41].”
BackgroundSterol Composition Modulates the Response of Saccharomyces cerevisiae to Iron Deficiency
Jordá, T., Rozés, N., & Puig, S. (2021) · Journal of Fungi · doi:10.3390/jof7110901 · Cited by 14
“The disruption of UPC2 in the fungal commensal-pathogen Candida albicans, which does not have an ECM22 paralog, has been shown to preclude activation of iron-related genes and limit growth in low-iron conditions [36].”
BackgroundDistinguishing mutants that resist drugs via different mechanisms by examining fitness tradeoffs
Schmidlin, K., Apodaca, S., Newell, D., Sastokas, A., Kinsler, G., & Geiler‐Samerotte, K. (2024) · eLife · doi:10.7554/elife.94144 · Cited by 18
“The 100 mutants with highest fitness in high FLU are blue, highest fitness in high RAD are red, and the seven that overlap between the two aforementioned categories are black.”
Asmiteh, F., Lagzian, M., Valadan, R., Abastabar, M., Shokohi, T., Hedayati, M. T., Parsay, S., Saravani, A., & Moazeni, M. (2025) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2024.101530 · Cited by 8
Reitler, P., Regan, J., DeJarnette, C. A., Srivastava, A., Carnahan, J., Tucker, K. M., Meibohm, B., Peters, B. M., & Palmer, G. E. (2024) · Infection and Immunity · doi:10.1128/iai.00072-24 · Cited by 8
“Activity of the non-steroidal anti-inflammatory drug, etofenamate, is dependent upon Upc2p, a transcription factor that activates the expression of genes encoding the enzymes required for ergosterol biosynthesis (18).”
Kakade, P., Mahadik, K., Balaji, K. N., Sanyal, K., & Nagaraja, V. (2018) · FEMS Yeast Research · doi:10.1093/femsyr/foy078 · Cited by 6
Schmidlin, K., Apodaca, S., Newell, D., Sastokas, A., Kinsler, G., & Geiler‐Samerotte, K. (2024) · eLife · doi:10.7554/elife.94144.1 · Cited by 7
Iron Acquisition in the Pathobiology of Candida albicans
Srivastav, M. K., Nair, R., & Natarajan, K. (2017) · Springer eBooks · doi:10.1007/978-3-319-50409-4_17 · Cited by 5
Rogers, P. D. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01143-y · Cited by 5
Self-citationAzoles Used in Agriculture as Possible Cause of Azole-Resistance in Clinical Candida Isolates
Kaur, H., Yadav, A., Wadhwa, K., Jain, K., & Ghorai, S. M. (2021) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/2884 · Cited by 7
Hang, S., Wang, L., Ji, Z., Shen, X., Fang, X., Li, W., Jiang, Y., & Lu, H. (2025) · Antibiotics · doi:10.3390/antibiotics14080799 · Cited by 6
“Research has demonstrated that the deletion of the UPC2 gene increases the susceptibility of C. albicans to azole therapies, particularly in strains exhibiting high levels of azole resistance, due to the presence of multiple resistance mechanisms [35–38].”
Bioactive Potential of Streptomyces Spp. Against Diverse Pathogenic Fungi
Harsha, H., Kumar, M., Kumar, P., Solanki, R., & Kapur, M. K. (2024) · Springer eBooks · doi:10.1007/978-981-97-5165-5_21 · Cited by 3
Inhibition of Candida albicans virulence by moscatin from Dendrobium nobile lindl.
Wang, B., Tan, H., Sun, X., Lin, Z., Chen, X., Han, H., Wang, M., Wang, Z., Chen, X., Deng, Y., et al. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.107089 · Cited by 3
Shrivastava, M., Kouyoumdjian, G. S., Kirbizakis, E., Ruiz, D., Henry, M., Vincent, A. T., Sellam, A., & Whiteway, M. S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.24.524502 · Cited by 2
“485 [34] Vasicek EM, Berkow EL, Flowers SA, Barker KS, Rogers PD.”
BackgroundYu, J., Jiang, B., Xiong, J., Xu, X., Xu, L., Jiang, Y., & Lu, H. (2026) · Pathogens · doi:10.3390/pathogens15060629 · Cited by 2
Zhu, W., & Guo, L. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1811011 · Cited by 5
“It activates the transcription of multiple ergosterol pathway genes, including ERG2 , ERG3 , and ERG11 , by binding to sterol response elements (SREs) (Oliver et al., 2007; Vasicek et al., 2014).”
Morschhäuser, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-50409-4_19 · Cited by 1
Yadav, V., & Soni, M. (2014)
An Investigation into Clinically Relevant Determinants of Azole Resistance in Candida albicans
Nishimoto, A. T. (2019) · doi:10.21007/etd.cghs.2019.0486
“When UPC2 was disrupted, the ∆upc2 mutants had decreased cellular ergosterol content and were more susceptible to fluconazole not only in the azole-susceptible SC5314 strain but also in a highly resistant clinical isolate 12-99 which overexpresses CDR1, MDR1, ERG11 and possesses a mutation in ERG11, suggesting that UP…”
BackgroundDistinguishing mutants that resist drugs via different mechanisms by examining fitness tradeoffsPreprint
Schmidlin, K., Apodaca, Newell, Sastokas, Kinsler, G., & Geiler‐Samerotte, K. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.17.562616
“However, sorting mutants into groups using a pairwise correlation plot ( Figure 2E ) excludes data from ten of our twelve environments.”
Distinguishing mutants that resist drugs via different mechanisms by examining fitness tradeoffsPreprint
Schmidlin, K., Apodaca, S., Newell, D., Sastokas, A., Kinsler, G., & Geiler‐Samerotte, K. (2024) · eLife · doi:10.7554/elife.94144.2
Feng, Y., Zhen, C., Li, W., Whiteway, M. S., Fang, X., Shen, X., Jiang, Y., & Lu, H. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.15.676225
Wang, D., An, N., Yang, Y., Yang, X., Fan, Y., & Feng, J. (2021) · Figshare · doi:10.6084/m9.figshare.14220996
Wang, D., An, N., Yang, Y., Yang, X., Fan, Y., & Feng, J. (2021) · Figshare · doi:10.6084/m9.figshare.14221002
Wang, D., An, N., Yang, Y., Yang, X., Fan, Y., & Feng, J. (2021) · Figshare · doi:10.6084/m9.figshare.14220999
Zhang, D., XiaoXing, L., Zhao, X., Yan, Z., Wang, W., & Dai, G. (2026) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2026.2655675 · Cited by 1
“…the regulator UPC2 exhibit iron-deprivation-mediated sensitivity, with deregulated iron homeostasis directly linked to heightened susceptibility (vasicek et al. 2014). thermal stress responses, governed by the critical Hsf1-HSe axis for thermal homeostasis, involve Hsf1-mediated signaling…”
Emerging Antifungal Resistance in Ocular Infections
de Oliveira, H. C., Tabuse, A. M., Höfling-Lima, A. L., & Rodrigues, A. M. (2026) · Springer eBooks · doi:10.1007/978-3-032-19923-2_3
Feng, Y., Zhen, C., Li, W., Whiteway, M. S., Fang, X., Shen, X., Jiang, Y., & Lu, H. (2026) · Microbiological Research · doi:10.1016/j.micres.2026.128595 · Cited by 4
Xu, H., Mao, Y., Hu, Y., Huang, J., Chen, W., & Lu, L. (2026) · Microbial Genomics · doi:10.1099/mgen.0.001812
“These include mutations within promoter regions or alterations in transcriptional regulatory networks, as observed in other fungal models [51, 52].”
Wang, H., Zhang, G., Chen, Q., Che, Z., Ma, Y., Hu, S., Qian, J., Xu, X., Chen, Y., Liu, Z., et al. (2026) · Advanced Agrochem · doi:10.1016/j.aac.2026.10.015
Metadata
- Authors
- Vasicek, E. M., Berkow, E. L., Flowers, S. A., Barker, K. S., & Rogers, P. D.
- Affiliations
- University of Tennessee Health Science Center (US)
- Venue
- Eukaryotic Cell
- Publisher
- American Society for Microbiology
- Published
- 2014-07
- Volume
- 13
- Issue
- 7
- Pages
- 933-946
- ISSN
- 1535-9778 (ISSN-L)
- 1535-9786
- PMC
- PMC4135735
- OpenAlex
- W2046705160
- Cited by
- 71
- References
- 53
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 10 · 2023: 6 · 2022: 6 · 2021: 7 · 2020: 6 · 2019: 8 · 2018: 5 · 2017: 3 · 2016: 3 · 2015: 4 · 2014: 2
- FWCI
- 2.80
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Eukaryotic Cell (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R01AI058145)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Keywords
- Candida albicans, azole resistance, fluconazole susceptibility, ergosterol biosynthesis, minimum fungicidal concentration, fungistatic activity, iron homeostasis, iron transport genes, antifungal drug targets
- MeSH terms
- Antifungal Agents, Candida albicans, Fungal Proteins, Transcription Factors, Fluconazole, Drug Resistance, Fungal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.